Repligen Corp reports results for the quarter ended December 31 - Earnings Summary

Repligen

20/02/2025 14:32

* Repligen Corp  RGEN.OQ  reported quarterly adjusted
earnings of
44 cents​​ per share for the quarter ended December 31, higher
than the same quarter last year, when the company reported EPS
of 33 cents.  The mean expectation of nineteen analysts for the
quarter was for earnings of 41 cents per share. Wall Street
expected results to range from 35 cents to 46 cents per share.
    * Revenue rose 7.6% to $167.55 million from a year ago;
analysts
expected $167.67 million. 
    * Repligen Corp's reported EPS for the quarter was a loss
of 60
cents​.
    * The company reported a quarterly loss of $33.87 million.
    * Repligen Corp shares had risen by 4.7% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 14 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Repligen Corp is
$190.00 
This summary was machine generated from LSEG data February 20 at
02:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      0.41           0.44           Beat
 Sep. 30 2024      0.33           0.43           Beat
 Jun. 30 2024      0.33           0.33           Met
 Mar. 31 2024      0.30           0.28           Missed